Drawing for UVLRX THERAPEUTICS

USPTO serial 86335242

UVLRX THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 4956538Status 710
Filing date
Status date
Registration date
May 10, 2016
Examiner
HELFMAN, JUDITH MICHELLE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with UVLRX THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kenneth T. Emanuelson

Kenneth T. Emanuelson The Emanuelson Firm17304 Preston Road Suite 800Dallas, TX 75252UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical devices, namely, intravenous blood irradiation devices that use radiation for treatment of blood to modulate the immune system, reduce pathogens, reduce inflammation, increase adenosine triphosphate (ATP) synthesis and improve hemodynamics and blood oxygen transport, reduce pain and improve wound healingSECTION 8 - CANCELLEDOct 7, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 25, 2022C8..CANCELLED SEC. 8 (6-YR)—
Sep 22, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 10, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 11, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 11, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 10, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 5, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 2, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 2, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 31, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 25, 2016IUAFUSE AMENDMENT FILED—
Feb 25, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 25, 2015ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 25, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 30, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 30, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 28, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 26, 2015ALIEASSIGNED TO LIE—
Apr 29, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 28, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 27, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 27, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 27, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 28, 2014GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 28, 2014GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 28, 2014CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 22, 2014DOCKASSIGNED TO EXAMINER—
Jul 18, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jul 17, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 15, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance